<DOC>
	<DOCNO>NCT02202278</DOCNO>
	<brief_summary>The aim study determine serum oxidative stress status ischemia modify albumin ( IMA ) , total antioxidant capacity ( TAC ) , total oxidative capacity ( TOS ) , oxidative stress capacity ( OSI ) , serum malondialdehyde ( MDA ) patient OHHS control group . We also aim reveal association serum level factor oocyte quality .</brief_summary>
	<brief_title>Study Serum Levels Oxidative Stress Markers Ovarian Hyperstimulation Patients</brief_title>
	<detailed_description>- Patients include study assist reproductive technique ( ART ) patient moderate severe OHSS hospitalize management - Control patient select patient without sign OHSS - All patient administer luteal long protocol control ovarian stimulation . Pituitary down-regulation SC injection GnRH agonist ( GnRH-a ) ( 1 mg/day ; Lucrin , Abbott Laboratories , North Chicago , IL ) start day 21 previous menstrual cycle . Subcutaneous administration recombinant hFSH ( Gonal-F , Laboratories Serono S.A. , Aubonne , Switzerland ) dosages 150-225 IU/day initiate second third day menstruation . - When least two three follicle &gt; 17 mm diameter , recombinant human chorionic gonadotropin ( 0.25 µgr ; Ovitrelle IM , Serono , Istanbul , Turkey ) apply subcutaneously 34-36 hour oocyte retrieval . - Serum sample collect day HCG study control group patient . - Serum level ischemia modify albumin ( IMA ) , malondialdehyde ( MDA ) , total oxidative capacity ( TOS ) , total antioxidative capacity ( TAS ) oxidative stress capacity ( OSI ) level . - This case control study - Statistical analysis perform use student t-test fisher chi-square test . The correlation serums IMA , TAC , TOC , OSI , MDA level examine study group use Spearman correlation analysis .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>• Patients group normoresponders hyperresponders undergo assist reproductive technology male factor know inherited acquire thrombophilia previous thromboembolism previous , current plan antithrombotic treatment first degree relative know genetic thrombophilia systemic disease smoke .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>ovarian hyperstimulation</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>IMA</keyword>
	<keyword>OHSS</keyword>
	<keyword>ICSI</keyword>
	<keyword>long agonist protocol</keyword>
	<keyword>TAC</keyword>
	<keyword>TOS</keyword>
	<keyword>OSI</keyword>
	<keyword>MDA</keyword>
</DOC>